- Home
- NUS vs ABSI Comparison
NUS vs ABSI Comparison
Compare NUS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- ABSI
- Stock Information
- Founded
- NUS 1984
- ABSI 2011
- Country
- NUS United States
- ABSI United States
- Employees
- NUS N/A
- ABSI N/A
- Industry
- NUS Other Pharmaceuticals
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- NUS Health Care
- ABSI Health Care
- Exchange
- NUS Nasdaq
- ABSI Nasdaq
- Market Cap
- NUS 379.5M
- ABSI 338.0M
- IPO Year
- NUS 1996
- ABSI 2021
- Fundamental
- Price
- NUS $8.95
- ABSI $2.76
- Analyst Decision
- NUS Hold
- ABSI Strong Buy
- Analyst Count
- NUS 2
- ABSI 5
- Target Price
- NUS $6.88
- ABSI $8.40
- AVG Volume (30 Days)
- NUS 511.8K
- ABSI 3.9M
- Earning Date
- NUS 08-07-2025
- ABSI 08-13-2025
- Dividend Yield
- NUS 2.69%
- ABSI N/A
- EPS Growth
- NUS N/A
- ABSI N/A
- EPS
- NUS N/A
- ABSI N/A
- Revenue
- NUS $1,679,268,000.00
- ABSI $4,815,000.00
- Revenue This Year
- NUS N/A
- ABSI $81.76
- Revenue Next Year
- NUS N/A
- ABSI $287.79
- P/E Ratio
- NUS N/A
- ABSI N/A
- Revenue Growth
- NUS N/A
- ABSI N/A
- 52 Week Low
- NUS $5.32
- ABSI $2.01
- 52 Week High
- NUS $11.64
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- NUS 67.91
- ABSI 47.40
- Support Level
- NUS $7.86
- ABSI $2.49
- Resistance Level
- NUS $8.16
- ABSI $2.86
- Average True Range (ATR)
- NUS 0.34
- ABSI 0.16
- MACD
- NUS 0.08
- ABSI -0.01
- Stochastic Oscillator
- NUS 92.57
- ABSI 42.78
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.